# Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo

> **NCT01612221** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 100 (actual)

## Conditions studied

- Patients at Risk for Melanoma

## Interventions

- **DRUG:** N-acetylcysteine
- **OTHER:** Placebo arm

## Key facts

- **NCT ID:** NCT01612221
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612221, "Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01612221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*